Literature DB >> 31191837

ANXA2, PRKCE, and OXT are critical differentially genes in Nonalcoholic fatty liver disease.

Mostafa Rezaei Tavirani1, Majid Rezaei Tavirani2, Mona Zamanian Azodi1.   

Abstract

AIM: Identification of prominent genes which are involved in onset and progress of steatosis stage of Nonalcoholic fatty liver disease (NAFLD) is the aim of this study.
BACKGROUND: NAFLD is characterized by accumulation of lipids in hepatocytes. The patients with steatosis (the first stage of NAFLD) will come across nonalcoholic steatohepatitis (NASH) and finally hepatic cirrhosis. There is correlation between cirrhosis and hepatic cancer. However, ultrasonography is used to diagnose NAFLD, biopsy is the precise diagnostic method.
METHODS: Gene expression profiles of 14 steatosis patients and 14 controls are retrieved from gene expression omnibus (GEO) and after statistical validation top 250 differentially expressed genes (DEGs) were determined. The characterized DEGs were included in network analysis and the central DEGs were identified. Gene ontology (GO) performed by ClueGO analysis of DEGs to determine critical biological terms. Role of prominent DEGs in steatosis is discussed in details.
RESULTS: Numbers of 31 significant DEGs including 20 up-regulated and 11 down-regulated ones were determined. Nine biological groups including 27 terms were recognized. Negative regulation of low-density lipoprotein particle receptor catabolic process, TRAM-dependent toll-like receptor signaling pathway, and regulation of hindgut contraction which were related to ANXA2, PRKCE, and OXT respectively were determined as critical biological term groups and DEGS.
CONCLUSION: Deregulation of ANXA2, PRKCE, and OXT is a critical event in steatosis. It seems these three genes are suitable biomarker to diagnosis of steatosis.

Entities:  

Keywords:  Biomarker; Gene; Nonalcoholic fatty liver disease

Year:  2019        PMID: 31191837      PMCID: PMC6536018     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


Introduction

Accumulation of lipids in hepatocytes occurs in NAFLD which is seen in association with various diseases, toxins, and drugs. There is evidence that level hepatic enzymes change significantly. Steatosis is the first stage of NAFLD which can convert to nonalcoholic steatohepatitis (NASH) and finally cirrhosis (1, 2). There is correlation between cirrhosis and liver cancer (3). Usually, ultrasonography check of liver is diagnostic method for NAFLD. However, precious diagnosis requires liver biopsy (4). Several attempts are done to find noninvasive biomarkers for NAFLD. Proteomics, genomics, metabolomics, and bioinformatics are used to analyze molecular aspect of NAFLD (5-8). In one study cytokeratin-18 fragment level is introduced as noninvasive biomarker for NAFLD while in the other investigation a large number of biomarkers are tabulated and introduced to diagnose NAFLD (9, 10). PPI network analysis is used to interact large numbers of proteins (or genes) in a network to provide possible screening tool. In this approach few genes among interacted genes play critical role to construct the network, and therefore have many connection with the other elements of the network. These types of genes are known as hubs. The other types of important elements of network are known as bottlenecks. The common hubs and bottlenecks are famous as hub-bottlenecks (11, 12). Gene ontology is useful method to identify biological terms related to investigate genes. In this regard, molecular function, biological processes, cellular component, and biochemical pathways as molecular features related to the query genes recognize (13). In this study, gene expression profiles of NAFLD (steatosis stage) patients are compared with control (data are retrieved from GEO) and the significant DEGs are included into interactome to find critical genes which are involved in NAFLD. Gene ontology is used to identify biological terms related to NAFLD. The finding can be considered to determine possible diagnostic and therapeutic biomarkers.

Methods

Gene expression profiles of 14 non-alcoholic fatty liver disease (NAFLD) stage steatosis patients and 14 controls, series GSE48452, GPL11532 were obtained from GEO. Demography of samples are tabulated in the table 1 (14). Liver biopsy samples were analyzed by array-based DNA methylation and mRNA expression. Profiles were compared via boxplot analysis and top 250 significant DEGs were considered for more analysis. The characterized DEGs with fold change more than 1.5 were determined and included in PPI network. The query DEGs and 100 added relevant genes were included in network to constructed PPI network by using STRING database and Cytoscape software (15, 16). The network was analyzed via Network analyzer plugin of Cytoscpe software. Biological terms relative to the query DEGs were determined and clustered by ClueGO (17). Critical DEGs based on network analysis and GO enrichment were determined. For more understanding a PPI network including the critical DEGs and their direct neighbors was built.
Table 1

Demography of controls and patients    (14) 

RAccessionGroupSexAgeBmi
1GSM1178970Controlmale5325.8
2GSM1178971Controlfemale5123.6
3GSM1178972Controlmale77*26.9*
4GSM1178973Controlmale2326.6
5GSM1178974Controlmale8025.8
6GSM1178977Controlmale6826.4
7GSM1178978Controlfemale4520.1
8GSM1178979Controlfemale4429.4
9GSM1178986Steatosisfemale4643.5
10GSM1178988Steatosisfemale2451.9
11GSM1178989Steatosisfemale3248.6
12GSM1178993Steatosisfemale38*42.4*
13GSM1178998Controlfemale2817.4
14GSM1178999Steatosisfemale4756
15GSM1179009Controlfemale38*30.0*
16GSM1179010Controlfemale4223.3
17GSM1179011Steatosismale6140.3*
18GSM1179018Controlfemale7321
19GSM1179021Steatosismale38*55.5*
20GSM1179023Steatosisfemale3340.9
21GSM1179024Controlfemale4424.9
22GSM1179025Steatosisfemale39*53.6*
23GSM1179027Steatosismale47*47.9*
24GSM1179029Steatosismale6543.7
25GSM1179031Controlfemale60*30.8*
26GSM1179034Steatosisfemale4249.6
27GSM1179037Steatosisfemale3260.2
28GSM1179040Steatosisfemale39*41.8*

Results

Gene expression profiles of 14 steatosis samples and 14 controls are analyzed via boxplot analysis. As it is shown in the figure 1 data obey from median centered distribution, therefore they are statistically comparable.
Figure 1

Boxplot presentation of gene expression profiles of 14 steatosis patients and 14 controls

Boxplot presentation of gene expression profiles of 14 steatosis patients and 14 controls LogFC 31 DEGs including 20 up-regulated and 11 down-regulated ones is illustrated Among 250 top significant DEGs, 31 individuals were characterized and included in network construction. In figure 2, the 31 DEGs and their LogFC are shown. In this figure, it is appeared that there are 20 up – regulated and 11 down – regulated DEGs. The network was built by 31 query DEGs and 100 added relevant ones. As it is illustrated in figure 3, 4 DEGs were not recognized and the network was constructed by 127 nodes and 1576 edges.
Figure 2

LogFC 31 DEGs including 20 up-regulated and 11 down-regulated ones is illustrated

Figure 3

The main connected component including 120 nodes and 1576 edges is shown. The nodes are layout based on degree value. PRKCE, OXT, and ANXA2, the query DEGs are shown in the left side of figure

Figure 4

Nine groups including 27 terms relevant to the 31 DEGs are shown

The main connected component including 120 nodes and 1576 edges is shown. The nodes are layout based on degree value. PRKCE, OXT, and ANXA2, the query DEGs are shown in the left side of figure Nine groups including 27 terms relevant to the 31 DEGs are shown Numbers of 7 nodes were isolated and the main connected component contains 120 nodes. Biological terms relative to the 31 DEGs are presented in the figure 4. The 27 terms are grouped in 9 classes. Details of figure 4 and additional information are tabulated in table 2. As it is shown in this table only 9 genes among 31 DEGs are involved in the biological terms. As it is shown in the figure 3 and table 2 three important DEGs are included PRKCE, OXT, and ANXA2. These three DEGs and their direct neighbors are shown in figure 5.
Table 2

Numbers of 27 terms relevant to the 31 DEGs are clustered in the 9 groups. %G/T refers to percentage of genes that are involved in term. Gene column shows the gene which participates in the related term

RGO TermOntology SourceGroup% G/TGene
1 pyruvate secondary active transmembrane transporter activity GO_MolecularFunction-EBI-QuickGO-GOA_20.11.2017_00h001100SLC16A7
2 CSAD decarboxylates 3-sulfinoalanine to hypotaurine REACTOME_Reactions_20.11.20172100CSAD
3 HSD17B11 dehydrogenates EST17b to E1 3100HSD17B11
4 STARD5 binds DCA, LCA 4100STARD5
5 Golgi to plasma membrane CFTR protein transport GO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00550KRT18
6 Defective ABCC6 causes pseudoxanthoma elasticum (PXE) REACTOME_Pathways_20.11.20176100ABCC6
7Defective ABCC6 does not transport organic anion from cytosol to extracellular regionREACTOME_Reactions_20.11.2017
8Oxytocin receptor bind oxytocin750OXT
9 regulation of hindgut contraction GO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00
10positive regulation of hindgut contraction100
11DAG stimulates protein kinase C-delta850PRKCE
12 TRAM-dependent toll-like receptor signaling pathway
13TRAM-dependent toll-like receptor 4 signaling pathway
14positive regulation of cellular glucuronidation100
15Expression of annexin A2REACTOME_Reactions_20.11.2017950ANXA2
16negative regulation of development of symbiont involved in interaction with hostGO_BiologicalProcess-EBI-QuickGO-GOA_20.11.2017_00h00100
17positive regulation of low-density lipoprotein particle clearance
18catabolism by organism of protein in other organism involved in symbiotic interaction
19catabolism by host of substance in symbiont
20metabolism by host of symbiont macromolecule
21metabolism by host of symbiont protein
22 negative regulation of low-density lipoprotein particle receptor catabolic process 50
23catabolism by host of symbiont macromolecule100
24positive regulation of low-density lipoprotein particle receptor binding
25positive regulation of low-density lipoprotein receptor activity
27catabolism by host of symbiont protein
27positive regulation of receptor-mediated endocytosis involved in cholesterol transport50
Figure 5

Network including PRKCE, OXT, and ANXA2 and their direct neighbors is illustrated. The nodes are layout based on degree value. Bigger size is corresponded to high value of degree. Color from blue to red refers to increment of degree value

Network including PRKCE, OXT, and ANXA2 and their direct neighbors is illustrated. The nodes are layout based on degree value. Bigger size is corresponded to high value of degree. Color from blue to red refers to increment of degree value Boxplot analysis of gene expression profiles of 4 control in comparison with 4 steatosis patients samples Considering important role of oxytocin in our study and well-known function of this hormone in females, expression change of OXT in male patients and control was investigated. Therefore, possible bias of sex effect is considered. It was appeared that fold change of oxytocin was equal to 3.76 (LogFC = 1.91) and this hormone was the top deregulated DEGs. Demography of samples and boxplot analysis are shown in table 3 and figure 6.
Table 3

Demography of 4 male patients and 4 male controls which their gene expression profiles are compared is shown

RAccessionGroupSexAgeBmi
1GSM1178970Controlmale5325.8
3GSM1178972Controlmale77*26.9*
4GSM1178973Controlmale2326.6
6GSM1178977Controlmale6826.4
17GSM1179011Steatosismale6140.3*
19GSM1179021Steatosismale38*55.5*
23GSM1179027Steatosismale47*47.9*
24GSM1179029Steatosismale6543.7
Figure 6

Boxplot analysis of gene expression profiles of 4 control in comparison with 4 steatosis patients samples

Demography of controls and patients    (14) Numbers of 27 terms relevant to the 31 DEGs are clustered in the 9 groups. %G/T refers to percentage of genes that are involved in term. Gene column shows the gene which participates in the related term Demography of 4 male patients and 4 male controls which their gene expression profiles are compared is shown

Discussion

Gene profile analysis can provide useful information about molecular mechanism of diseases (18, 19). In this study network analysis is used to screen significant DEGs which differentiated steatosis stage of NAFLD patients from controls. As it is shown in the figure 1, statistically samples are comparable because distribution of data is median centric. Therefore, more investigations about samples are possible. As it is shown in figure 2, up-regulation is prominent relative to down-regulation in NAFLD. Numbers of 20 DEGs are up-regulated while 11 down-regulated genes are represented. However, PRDM10, PIK3CA, GAPDH, ALB, SRC, and TP53 are the hubs of the network but PRKCE, OXT, and ANXA2 the query DEGs play significant roles in the PPI network. PRKCE and OXT are upregulated genes while ANXA2 is down regulated one (see figure 2). In figure 3, positions of these three DEGs relative to the other query DEGs are layout and illustrated. The other query DEGs are characterized with weak centrality role in the network. Among 31 DEGs, seven ones containing BEAN1, CCDC82, GOLGA8O, GOLGA8T, HAPLN4, RAPGEFL1, and STARD5 were not included in the network and remained as isolated nodes. GO analysis indicates that 9 DEGs are involved in the 27 biological terms which are clustered in the 9 groups (see figure 4 and table 2). Group 9: negative regulation of low-density lipoprotein particle receptor catabolic process is the largest group including 13 biological terms. The second and third larger groups (groups 8 and 7) are TRAM-dependent toll-like receptors signaling pathway (including 4 terms) and regulation of hindgut contraction (containing 3 terms), respectively. ANXA2, PRKCE, and OXT are complicated in the groups 9, 8, and 7, respectively. These three DEGs are involved in 20 terms (74% of all biological Terms). As it is shown in the figure 5, 77 nodes (64% of PPI network nodes) are directly linked to PRKCE, OXT, and ANXA2. It seems ANXA2, PRKCE, and OXT are central DEGs among 31 query DEGs which their deregulation is functionally significant event in NAFLD. Since oxytocin is a well-known female hormone and there are no sufficient documents about its role in men, we design another analysis that was resulted from comparison between male patients and control (see table 3 and figure 6). In this analysis OXT appeared as the top DEGs based on fold change. Therefore, presence of oxytocin among three important DEGs in NAFLD is depended to both male and female patients. Four biological terms in group 9 are about regulation of low-density lipoprotein (LDL). LDL is a cholesterol-carrying agent in human plasma which LDL receptor regulates its plasma level. Investigation showed that raising cholesterol content of liver hepatocytes leads to fall of LDL receptors in liver which causes increment of LDL level of plasma. This process is seen after digestion of diets rich in saturated fat and cholesterol (20). It seems that deregulation of ANXA2 effects on storage of fat in lever via deregulation of clearance of plasma cholesterol. Sun et al. reported that there is correlation between low-density lipoprotein cholesterol and NAFLD prevalence (21). However, role of ANXA2 in NAFLD is reported previously, here it is introduced as the top related gene in NAFLD (especially steatosis stage). Positive regulation of cellular glucuronidation is one of group 8 biological process. Glucuronidation is a major biochemical pathway that plays role in cellular detoxification. In this pathway, the highly hydrophilic glucuronide group transfers to hydrophobic substrates which are less toxic and can be exerted easily relative to the initial substances (22). Role of this protective process was studied in drug metabolism of NAFLD patients (23). It can be concluded that up-regulation of PRKCE which promotes positive regulation of cellular glucuronidation is a protecting activity in NAFLD. Regulation of hindgut contraction is a term which is related to oxytocin. It is reported that positive regulation of hindgut (the posterior part of the alimentary canal, including the rectum, and the large intestine) is appositive regulation of smooth muscle which positively regulates hindgut contraction. This terms is responsible for positive regulation of digestion (https://www.ebi.ac.uk/QuickGO/term/GO:0060450). In conclusion up-regulation of OXT stimulates digestion in steatosis stage of NAFLD. Precious analysis revealed that ANXA2, PRKCE, and OXT are three important genes that are involved in steatosis stage of NAFLD. Significant expression change, participation in prominent biochemical pathways, and large number of connections with the other genes imply that these DEGs be considered as critical genes relative to NAFLD. It can be suggested that suitable quantity profiles of ANXA2, PRKCE, and OXT be validated to manage steatosis stage of NAFLD.
  23 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

2.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

3.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

4.  Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease.

Authors:  Chaohui Yu; Chengfu Xu; Lei Xu; Jiekai Yu; Min Miao; Youming Li
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

5.  Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada; Yasuo Ohashi
Journal:  Hepatol Res       Date:  2006-06-05       Impact factor: 4.288

6.  In vivo gene expression profile analysis of human breast cancer progression.

Authors:  D C Sgroi; S Teng; G Robinson; R LeVangie; J R Hudson; A G Elkahloun
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

Review 7.  Genomic aspects of NAFLD pathogenesis.

Authors:  Adviti Naik; Rok Košir; Damjana Rozman
Journal:  Genomics       Date:  2013-03-29       Impact factor: 5.736

8.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

9.  Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Authors:  Ariel E Feldstein; Anna Wieckowska; A Rocio Lopez; Yao-Chang Liu; Nizar N Zein; Arthur J McCullough
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  Molecular Interactions between NAFLD and Xenobiotic Metabolism.

Authors:  Adviti Naik; Aleš Belič; Ulrich M Zanger; Damjana Rozman
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

View more
  4 in total

1.  Highlighted role of "IL17 signaling pathway" in gastroesophageal reflux disease.

Authors:  Mona Zamanian Azodi; Mohammadreza Razzaghi; Habib Malekpour; Majid Rezaei-Tavirani; Mostafa Rezaei-Tavirani; Mohammad Hossein Heidari
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

2.  Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.

Authors:  Zishuang Zhang; Zhi-Ping Liu
Journal:  BMC Med Genomics       Date:  2021-08-25       Impact factor: 3.063

3.  Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis.

Authors:  Kourosh Saki; Vahid Mansouri; Saeed Abdi; Mohammad Fathi; Zahra Razzaghi; Mehrdad Haghazali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

4.  Identification of Key LncRNAs and Pathways in Prediabetes and Type 2 Diabetes Mellitus for Hypertriglyceridemia Patients Based on Weighted Gene Co-Expression Network Analysis.

Authors:  Shoumeng Yan; Mengzi Sun; Lichao Gao; Nan Yao; Tianyu Feng; Yixue Yang; Xiaotong Li; Wenyu Hu; Weiwei Cui; Bo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.